TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Agrenius Lungmedicin AB
Closing information (x1000 DKK)
| Closing information | 2025/06 | 2024/06 | 2023/06 |
| Turnover |
384
|
397
|
436 |
| Financial expenses |
7
|
0
|
30 |
| Earnings before taxes |
351
|
48
|
39 |
| EBITDA |
-16
|
-3
|
68 |
| Total assets |
2,263
|
2,057
|
2,045 |
| Current assets |
143
|
262
|
185 |
| Current liabilities |
185
|
178
|
111 |
| Equity capital |
1,999
|
1,792
|
1,829 |
| - share capital |
67
|
66
|
63 |
| Employees (average) |
0
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Solvency |
88.3%
|
87.1%
|
89.4% |
| Turnover per employee |
397
|
436 | |
| Profit as a percentage of turnover |
91.4%
|
12.1%
|
8.9% |
| Return on assets (ROA) |
15.8%
|
2.3%
|
3.4% |
| Current ratio |
77.3%
|
147.2%
|
166.7% |
| Return on equity (ROE) |
17.6%
|
2.7%
|
2.1% |
| Change turnover |
-21
|
-56
|
-266 |
| Change turnover % |
-5%
|
-12%
|
-38% |
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-100%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.